Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Venous Tourniquet Method With Isolated Forearm Technique in Electroconvulsive Therapy
NCT07534475Recruiting
- Sponsor
- Istanbul Medipol University
- Start
- Apr 2026
- Primary completion
- Nov 2026
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of Sugammadex in neuromuscular blockade (NMB), sponsored by Istanbul Medipol University. Primary endpoint: Motor Seizure Duration up to 5 minutes. Started Apr 2026; status: recruiting.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT07534475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07534475.